Daraxonrasib's Breakthrough Comes With a Line-of-Therapy Trap
Daraxonrasib may be a real pancreatic-cancer advance, but patients need the second-line and first-line trials kept separate.
Kenji Nakamura
Bureau: Tokyo
Right Whales Had Their Best Calving Season in Seventeen Years and It Still Is Not Enough
Twenty-three calves is real good news, but a species of roughly 380 animals cannot afford triumphalism.
Sonrotoclax Shows the Promise and Fragility of Accelerated Approval
Sonrotoclax gives mantle cell lymphoma patients a new option, with the confirmatory evidence still ahead of it.
Airborne Microplastics Are Becoming a Climate-Forcing Story
A new model paper puts airborne microplastics into the climate-forcing conversation without making them climate's main character.
Microplastics Climate Coverage Needs a Scale Bar
Sixteen percent of black-carbon forcing is meaningful; it is not permission to make plastics the whole climate story.